One day after the U.S. Food and Drug Administration (FDA) granted emergency use authorization to Pfizer’s COVID-19 antiviral pill, Paxlovid, the agency on Thursday granted the same emergency use authorization to Merck’s antiviral medication, molnupiravir. Both pills are intended only for people who are at high risk for hospitalization and death from severe …
Read More »